Lee, at this point in the year, all the companies that pay dividends have pretty much set their dividends. You know, the ...

Shares of Abivax hit the stratosphere Wednesday after the firm unveiled "potentially disruptive" results for its ulcerative ...

The One Big Beautiful Bill Act (OBBBA), signed into law by President Donald Trump on July 4, 2025, provides for enhanced restrictions on ...

The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by risi ...

Severe tropical storm Crising dumped so much rainwater all over Metro Manila and nearby provinces in Luzon. Crising was the third of the average 20 typhoons that visit our country each year. From the ...

Pfizer's $43B Seagen deal strengthens its oncology portfolio, offsets patent cliffs, and offers 70%+ upside potential. See ...

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

U.S. stocks are rising toward another record following a trade deal between the world’s No. 1 and No. 4 economies, one that ...

The cancer pain market, valued at USD 6.53 billion in 2024, is projected to reach USD 11.81 billion by 2034, with a CAGR of 6 ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.